Used to treat severe, poorly controlled asthma who have eosinophil levels that are high. CINQAIR can reduce the number of these cells. CINQAIR has been proven to prevent asthma attacks (exacerbations) and help patients breathe better. It may also help you have fewer asthma symptoms and improve your quality of life.
A man-made form of a hormone called adrenocorticotropic hormone (ACTH). ACTH is a hormone that is normally produced by the pituitary gland in the brain. ACTH stimulates the adrenal glands to release the hormones cortisol and adrenaline.
Also known as: Burosumab-twza
A prescription medicine used to treat adults with X-linked hypophosphatemia (XLH). XLH is an inherited disorder characterized by low levels of phosphate in the blood.
An interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic.
Used to treat fluid retention (edema) and swelling caused by congestive heart failure, liver disease, kidney disease, and other medical conditions.
Used in a Glucagon stimulation test kit to identify growth hormone and cortisol.
Used to treat Vitamin B12 deficiency, Pernicious anemia, and cyanide poisoning.
Also known as: Immune Globulin Infusion 10% [Human] with Recombinant Human Hyaluronidase
A subcutaneous (subQ) Ig treatment for adults with primary immunodeficiency (PI). HyQvia is infused once a month.* With up to 28 days between infusions, you can focus less on managing your treatment schedule and more on living your life.
An iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in patients who have an intolerance to oral iron or have had unsatisfactory response to oral iron, and in patients with non-dialysis dependent chronic kidney disease.
A medicine to treat fluid retention (edema) and swelling caused by congestive heart failure, liver disease, kidney disease, and other medical conditions.
Also known as: Alemtuzumab
Used to treat chronic lymphocytic leukemia and multiple sclerosis. In CLL has been used as both a first-line and second-line treatment. In MS it is generally only recommended if other treatments have not worked.
An add-on, prescription maintenance treatment for patients 12 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems. It recognizes and blocks interleukin-5, a signaling protein of the immune system.
A prescription medicine used in combination with YERVOY® (ipilimumab) as a first treatment for adults with a type of advanced-stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread to other parts of your body (metastatic) and your tumors are positive for PD-L1, but do not have an abnormal EGFR or ALK gene.
It can treat high blood calcium levels. In addition it can treat bone damage caused by Paget’s disease, multiple myeloma, and cancers that spread to the bone. It can also treat osteoporosis and reduce the risk of hip fractures in certain patients.
Also known as: Infliximab
Used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, plaque psoriasis, and ulcerative colitis.
Used to treat certain autoimmune diseases such as Rheumatoid Arthritis, Granulomatosis with Polyangiitis (GPA) & Microscopic Polyangiitis (MPA), Pemphigus Vulgaris (PV) and certain types of cancer such as Non-Hodgkin’s Lymphona (NHL) and Chronic Lymphocytic Leukemia (CLL).
A prescription medicine used to treat adults with: Non-Hodgkin’s Lymphoma (NHL): alone or with other chemotherapy medicines. Chronic Lymphocytic Leukemia (CLL): with the chemotherapy medicines fludarabine and cyclophosphamide.
SAPHNELO™ is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. It is a fully human monoclonal antibody that binds to subunit 1 of the type I IFN receptor, blocking the activity of type I IFNs.
SAPHNELO™ is not indicated for severe active lupus nephritis or severe active CNS lupus.
A fully human monoclonal antibody inhibitor of insulin-like growth factor-1 (IGF-1R) that works by binding to IGF-1R/TSHR signaling complexes, blocking the auto-antibodies from attacking the orbital cells.
Used to help identify thyroid disease by testing the blood for a hormone called thyroglobulin in the follow up of patients with a certain type of thyroid cancer known as well-differentiated thyroid cancer.
Used for treatment of infections with gram-negative bacteria that have become resistant to conventional antibiotics. It was studied for urinary tract infections, intra-abdominal infections and ventilator-associated bacterial pneumonia.
Also known as: Bezlotoxumab
A human monoclonal antibody to reduce CDI recurrence, in patients receiving antibacterial drug treatment of CDI who are at high risk for CDI recurrence.
Used to treat prostate and breast cancer. It can also treat precocious puberty. In women, it can also treat endometriosis and thin the lining of the uterus before surgery.
It can treat high blood calcium levels. In addition, it can treat bone damage caused by Paget’s disease, multiple myeloma, and cancers that spread to the bone. It can also treat osteoporosis and reduce the risk of hip fractures in certain patients.